- Country: Brazil
- Summary: Price Registration, Aiming at Future and Possible Acquisitions of Medicines Case Grupo 2 Without Demand Part 1 - Annual Plan 2023, According to the Detailed Specifications Contained in this Public Notice and in the Table At...
- BRT Ref No: 82501602
- Deadline: 17 May 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 95/2023
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Purpose: Electronic Auction - Price registration, aiming at future and possible ACQUISITIONS OF CASE GRUPO 2 MEDICINES WITHOUT DEMAND PART 1 - ANNUAL PLAN 2023, according to the detailed specifications contained in this Notice and in the attached table. from: 05/03/2023 at 08:00492584800e8c8d91eb93b064ebe674eb0 to 1:00 pm and from 2:00 pm to 5:00 pm
Submission of the Proposal : from 05/03/2023 at 08:00 am
ACETAZOLAMIDE, DOSAGE 250 MG
Quantity : 1000
NICOTINIC ACID, CONCENTRATION 250 MG , PHARMACEUTICAL FORM EXTENDED RELEASE
Amount : 3600
NICOTINIC ACID, CONCENTRATION 500 MG, PHARMACEUTICAL FORM LIB492584800e8c8d91eb93b064ebe674ebEXTENDED ERATION
Amount : 3600
NICOTINIC ACID, CONCENTRATION 750 MG, PHARMACEUTICAL FORM EXTENDED RELEASE
Amount : 3600
ALFACALCIDOL, DOSAGE 1 MCG
Amount : 2790
FORMOTEROL FUMARATE, COMPOSITION ASSOCIATED WITH BUDESONIDE, CONCENTRATION 12 MCG 400 MCG/DOSE, PHARMACEUTICAL FORM INHALANT POWDER492584800e8c8d91eb93b064ebe674ebTE, ADDITIONAL CHARACTERISTICS WITH INHALER BOTTLE
Amount : 27000
FORMOTEROL FUMARATE, COMPOSITION ASSOCIATED WITH BUDESONIDE, CONCENTRATION 12 MCG 400MCG/DOSE, PHARMACEUTICAL FORM INHALANT POWDER, ADDITIONAL CHARACTERISTICS WITH INHALER BOTTLE
Amount : 9000
FORMOTEROL FU MARATE, ASSOCIATED COMPOSITIONO WITH BUDESONIDE, CONCENTRATION 6 MCG 200 MCG/DOSE, PHARMACEUTICAL FORM INHALANT POWDER, ADDITIONAL CHARACTERISTICS WITH INHALER BOTTLE
Amount : 14250
FORMOTEROL FUMARATE, COMPOSITION ASSOCIATED WITH BUDESONIDE, CONCENTRATION 6 MCG 200 MCG/DOSE, PHARMACEUTICAL FORM POWDER IN ALANTE, ADDITIONAL FEATURESWITH INHALER BOTTLE
Quantity : 4750
ATORVASTATIN CALCIUM, DOSAGE 40 MG
Quantity : 930
ATORVASTATIN CALCIUM, DOSAGE 80 MG
Quantity : 373
BEZAFIBRATE, DOSAGE 400 MG, PHARMACEUTICAL FORM SLOW DISINTEGRATION
Quantity : 463
BEZAFIBRATE, DOSAGE 200 MG
Amount : 3600
BRIMONIDINE TARTRATE,492584800e8c8d91eb93b064ebe674ebDOSAGE 2 MG/ML, EYE DROPS PRESENTATION
Amount : 1000
BRINZOLAMIDE, C... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPrice Registration, Aiming at Future and Possible Acquisitions of Medicines Case Grupo 2 Without Demand Part 1 - Annual Plan 2023, According to the Detailed Specifications Contained in this Public Notice and in the Table At... - Brazil Tender
The STATE HEALTH FUND, a Government sector organization in Brazil, has announced a new tender for Price Registration, Aiming at Future and Possible Acquisitions of Medicines Case Grupo 2 Without Demand Part 1 - Annual Plan 2023, According to the Detailed Specifications Contained in this Public Notice and in the Table At.... This tender is published on BrazilTenders under BRT Ref No: 82501602 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-05-17.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
